| 000 | 01681 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513202000.0 | ||
| 264 | 0 | _c20000303 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0002-8703 | ||
| 024 | 7 |
_a10.1067/mhj.2000.103741 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKereiakes, D J | |
| 245 | 0 | 0 |
_aPlatelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cFeb 2000 |
||
| 300 |
_aS53-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aElectrocardiography _xdrug effects |
| 650 | 0 | 4 | _aEptifibatide |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xtherapeutic use |
| 650 | 0 | 4 |
_aPeptides _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTirofiban |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 700 | 1 | _aMcDonald, M | |
| 700 | 1 | _aBroderick, T | |
| 700 | 1 | _aRoth, E M | |
| 700 | 1 | _aWhang, D D | |
| 700 | 1 | _aMartin, L H | |
| 700 | 1 | _aHoward, W L | |
| 700 | 1 | _aSchneider, J | |
| 700 | 1 | _aShimshak, T | |
| 700 | 1 | _aAbbottsmith, C W | |
| 773 | 0 |
_tAmerican heart journal _gvol. 139 _gno. 2 Pt 2 _gp. S53-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mhj.2000.103741 _zAvailable from publisher's website |
| 999 |
_c10605353 _d10605353 |
||